These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

620 related items for PubMed ID: 18546811

  • 1. Five-year clinical and histologic results following treatment of human intrabony defects with an enamel matrix derivative combined with a natural bone mineral.
    Sculean A, Chiantella GC, Arweiler NB, Becker J, Schwarz F, Stavropoulos A.
    Int J Periodontics Restorative Dent; 2008 Apr; 28(2):153-61. PubMed ID: 18546811
    [Abstract] [Full Text] [Related]

  • 2. Ten-year results following treatment of intrabony defects with an enamel matrix protein derivative combined with either a natural bone mineral or a β-tricalcium phosphate.
    Döri F, Arweiler NB, Szántó E, Agics A, Gera I, Sculean A.
    J Periodontol; 2013 Jun; 84(6):749-57. PubMed ID: 22873657
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Effect of platelet-rich plasma on the healing of intrabony defects treated with an enamel matrix protein derivative and a natural bone mineral.
    Döri F, Nikolidakis D, Húszár T, Arweiler NB, Gera I, Sculean A.
    J Clin Periodontol; 2008 Jan; 35(1):44-50. PubMed ID: 18034853
    [Abstract] [Full Text] [Related]

  • 5. Five-year results evaluating the effects of platelet-rich plasma on the healing of intrabony defects treated with enamel matrix derivative and natural bone mineral.
    Döri F, Arweiler N, Húszár T, Gera I, Miron RJ, Sculean A.
    J Periodontol; 2013 Nov; 84(11):1546-55. PubMed ID: 23327604
    [Abstract] [Full Text] [Related]

  • 6. Clinical comparison of an enamel matrix derivative used alone or in combination with a bovine-derived xenograft for the treatment of periodontal osseous defects in humans.
    Velasquez-Plata D, Scheyer ET, Mellonig JT.
    J Periodontol; 2002 Apr; 73(4):433-40. PubMed ID: 11990445
    [Abstract] [Full Text] [Related]

  • 7. Four-year results of a prospective-controlled clinical study evaluating healing of intra-bony defects following treatment with an enamel matrix protein derivative alone or combined with a bioactive glass.
    Sculean A, Pietruska M, Arweiler NB, Auschill TM, Nemcovsky C.
    J Clin Periodontol; 2007 Jun; 34(6):507-13. PubMed ID: 17451415
    [Abstract] [Full Text] [Related]

  • 8. Clinical evaluation of an enamel matrix protein derivative combined with either a natural bone mineral or beta-tricalcium phosphate.
    Döri F, Arweiler N, Gera I, Sculean A.
    J Periodontol; 2005 Dec; 76(12):2236-43. PubMed ID: 16332235
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Effect of platelet-rich plasma on the healing of intrabony defects treated with an anorganic bovine bone mineral: a pilot study.
    Döri F, Kovács V, Arweiler NB, Huszár T, Gera I, Nikolidakis D, Sculean A.
    J Periodontol; 2009 Oct; 80(10):1599-605. PubMed ID: 19792848
    [Abstract] [Full Text] [Related]

  • 13. Healing of two and three wall intrabony periodontal defects following treatment with an enamel matrix derivative combined with autogenous bone.
    Yilmaz S, Cakar G, Yildirim B, Sculean A.
    J Clin Periodontol; 2010 Jun; 37(6):544-50. PubMed ID: 20507378
    [Abstract] [Full Text] [Related]

  • 14. The effect of postsurgical antibiotics on the healing of intrabony defects following treatment with enamel matrix proteins.
    Sculean A, Blaes A, Arweiler N, Reich E, Donos N, Brecx M.
    J Periodontol; 2001 Feb; 72(2):190-5. PubMed ID: 11288792
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Clinical evaluation of an enamel matrix protein derivative combined with a bioactive glass for the treatment of intrabony periodontal defects in humans.
    Sculean A, Barbé G, Chiantella GC, Arweiler NB, Berakdar M, Brecx M.
    J Periodontol; 2002 Apr; 73(4):401-8. PubMed ID: 11990441
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Bioabsorbable membrane and bioactive glass in the treatment of intrabony defects in patients with generalized aggressive periodontitis: results of a 5-year clinical and radiological study.
    Mengel R, Schreiber D, Flores-de-Jacoby L.
    J Periodontol; 2006 Oct; 77(10):1781-7. PubMed ID: 17032123
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 31.